Posts in Risk Analysis
Risk Assessment of Nanomaterials

Our latest book chapter describes risk assessment frameworks and state-of-the-art approaches to assess nanomaterial risk with a specific focus on life-cycle risk analysis. Case studies for carbon nanotubes and cellulose nanomaterials put these theories into practice, guiding readers through model risk assessment processes.

Read More
Life-cycle risk assessment of graphene-enabled textiles in fire protection gear

Working with industrial partners in the DIAGONAL project, Vireo conducted a detailed nanomaterial life-cycle risk analysis (Nano LCRA) for a graphene-enabled functional fabric used in personal protective equipment. We are delighted to announce that this study has been published in NanoImpact. Using this unique link, you can read it without sign-up, registration or fees until January 25, 2024.

Read More
Establishing safety and supporting commercialization for renewable nanomaterials: Vireo at the TAPPI Nanotechnology Conference

Vireo has been working for the past decade to establish safety and support commercialization for microfibrillated cellulose, cellulose nanocrystals and a host of other emerging biomaterials. Our lead scientists are sharing their experience and provide practical guidance in presentations, posters, discussion panels and networking events at the 2023 TAPPI Nanotechnology Conference.

Read More
Cultured meat commercialization and regulatory roundup

Our roundup of the latest cultured meat developments includes announcements from Mosa Meats, Meatable, Aleph Farms, Smart MCs, and UPSIDE, plus commercially-relevant research from Tufts, Kobe University, and Enzymit, FDA approval for consumption of gene-edited pigs, regulatory and governmental perspectives on cultured meat safety research priorities from Vireo and New Harvest, and new labelling requirements in Texas.

Read More
Cultured meat: commercialization and regulatory roundup

At Vireo, we keep close surveillance on commercialization and regulatory developments in cultured and alt-protein meat and seafood, and we have rarely seen as much activity as this! Here is our roundup of the latest developments…

Read More
Climate change is a real business risk that can be managed.

In recent weeks we have seen U.S. Senators call climate change ‘ideology’, but overwhelming evidence reveals climate change as a real business risk – one that can, and must, be managed. At Vireo, we are working to gain market and regulatory acceptance of biobased, recycled, and advanced technologies that lower these risks.

Read More
EU Court overturns titanium dioxide carcinogen classification: A salutary tale for toxicity assessment.

In a landmark decision, the EU Court of Justice ruled that 2017 decisions on carcinogenicity for TiO2  did not rely on valid evidence. The animal studies used were not relevant to humans and they failed to show an intrinsic cause of cancer. The court decision has implications for the EU ban of TiO2 in food.

Read More